Results 241 to 250 of about 65,138,242 (275)

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

Modulating IL-21-driven B cell responses in idiopathic inflammatory myopathies via inhibition of the JAK/STAT pathway. [PDF]

open access: yesArthritis Res Ther
Merino-Vico A   +10 more
europepmc   +1 more source

Corrigendum: Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein. [PDF]

open access: yesFront Immunol
Kroenke MA   +16 more
europepmc   +1 more source

A novel feeder cell based on 4-1BBL and membrane-bound IL-21/IL-15 induce highly expansion and anti-tumor effect of natural killer cells. [PDF]

open access: yesBMC Biotechnol
Gong S   +12 more
europepmc   +1 more source

Corrigendum to 'B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis' [J Hepatol (2022) doi: 10.1016/j.jhepr.2022.100460]. [PDF]

open access: yesJHEP Rep
Biewenga M   +8 more
europepmc   +1 more source

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma. [PDF]

open access: yesMol Ther Oncol
Chu Y   +12 more
europepmc   +1 more source

Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC-I deficient solid tumors

open access: yes
Wang Y   +12 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Biology of IL‐21 and the IL‐21 receptor

Immunological Reviews, 2004
Summary:  Interleukin‐21 (IL‐21) is the newest member of the common γ‐chain family of cytokines, which includes IL‐2, IL‐4, IL‐7, IL‐9, IL‐13, and IL‐15. Its private receptor, IL‐21R, has been shown to activate the Janus kinase/signal transducers and activators of transcription signaling pathway upon ligand binding.
Devangi S, Mehta   +2 more
openaire   +2 more sources

High IL-21 receptor expression and apoptosis induction by IL-21 in follicular lymphoma

Cancer Letters, 2007
We surveyed IL-21 receptor (IL-21R) in leukemia and lymphoma and found that follicular lymphoma cells showed exceptionally high IL-21R expression. Notably, IL-21 showed divergent effects depending on the cell origin: growth stimulation in Burkitt lymphoma cell lines and adult T cell leukemia/lymphoma cell lines but induction of apoptosis in B lymphoma ...
Norihiko, Akamatsu   +13 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy